SCHEMBL8795299

SCHEMBL8795299

OCc1cccc(OC[C@@H]2CO2)c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.72
ALDH1A1 P00352 4/20 0.72
TP53 P04637 3/20 0.72
SMN1; SMN2 Q16637 2/20 0.72
HIF1A Q16665 2/20 0.72
CYP3A4 P08684 1/20 0.72
TDP1 Q9NUW8 1/20 0.59
MAPT P10636 2/20 0.44
HPGD P15428 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
CYP1A2 P05177 1/20 0.44
PPARG P37231 1/20 0.44
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.44
PKM P14618 1/20 0.44
GPBAR1 Q8TDU6 1/20 0.43
CYSLTR1 Q9Y271 1/20 0.43
GLA P06280 1/20 0.42
FGFR1 P11362 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL169942 1.00 TSHR (0.72) TSHRALDH1A1TP53SMN1; SMN2HIF1A
SCHEMBL19828239 0.85 ALDH1A1 (0.74) TSHRALDH1A1TP53SMN1; SMN2HIF1A
SCHEMBL37802 0.84 ALDH1A1 (1.00) TSHRALDH1A1TP53SMN1; SMN2HIF1A
SCHEMBL31537002 0.84 ALDH1A1 (1.00) TSHRALDH1A1TP53SMN1; SMN2HIF1A
SCHEMBL31537008 0.84 ALDH1A1 (1.00) TSHRALDH1A1TP53SMN1; SMN2HIF1A
SCHEMBL12289601 0.84 ALDH1A1 (1.00) TSHRALDH1A1TP53SMN1; SMN2HIF1A
SCHEMBL13806572 0.84 ALDH1A1 (1.00) TSHRALDH1A1TP53SMN1; SMN2HIF1A
SCHEMBL16527504 0.84 ALDH1A1 (0.72) TSHRALDH1A1TP53SMN1; SMN2HIF1A
SCHEMBL22855755 0.84 ALDH1A1 (0.72) TSHRALDH1A1TP53SMN1; SMN2HIF1A
SCHEMBL27697987 0.84 ALDH1A1 (0.72) TSHRALDH1A1TP53SMN1; SMN2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0611003-B1 Substituted phenyl sulfonamides as selective B3 agonists for the treatment of diabetes and obesity MERCK & CO INC (US) 1997-06-18 EP disclosed
US-5451677-A Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity MERCK & CO., INC. (US) 1995-09-19 US disclosed
EP-0611003-A1 Substituted phenyl sulfonamides as selective B3 agonists for the treatment of diabetes and obesity MERCK & CO. INC. (US) 1994-08-17 EP disclosed